354 related articles for article (PubMed ID: 12432296)
1. Conformal preoperative endorectal brachytherapy treatment for locally advanced rectal cancer: early results of a phase I/II study.
Vuong T; Belliveau PJ; Michel RP; Moftah BA; Parent J; Trudel JL; Reinhold C; Souhami L
Dis Colon Rectum; 2002 Nov; 45(11):1486-93; discussion 1493-5. PubMed ID: 12432296
[TBL] [Abstract][Full Text] [Related]
2. Is the Pathologic Response of T3 Rectal Cancer to High-Dose-Rate Endorectal Brachytherapy Comparable to External Beam Radiotherapy?
Garfinkle R; Lachance S; Vuong T; Mikhail A; Pelsser V; Gologan A; Morin NA; Vasilevsky CA; Boutros M
Dis Colon Rectum; 2019 Mar; 62(3):294-301. PubMed ID: 30741768
[TBL] [Abstract][Full Text] [Related]
3. Phase I dose escalating trial of hyperfractionated pre-operative chemoradiation for locally advanced rectal cancer.
Movsas B; Hanlon AL; Lanciano R; Scher RM; Weiner LM; Sigurdson ER; Hoffman JP; Eisenberg BL; Cooper HS; Provins S; Coia LR
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):43-50. PubMed ID: 9747818
[TBL] [Abstract][Full Text] [Related]
4. High-dose-rate endorectal brachytherapy in the treatment of locally advanced rectal carcinoma: technical aspects.
Vuong T; Devic S; Moftah B; Evans M; Podgorsak EB
Brachytherapy; 2005; 4(3):230-5. PubMed ID: 16182224
[TBL] [Abstract][Full Text] [Related]
5. Predicting residual rectal adenocarcinoma in the surgical specimen after preoperative brachytherapy with endoscopic ultrasound.
Romagnuolo J; Parent J; Vuong T; Bélanger M; Michel RP; Belliveau PJ; Trudel JL
Can J Gastroenterol; 2004 Jul; 18(7):435-40. PubMed ID: 15229745
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation.
Valentini V; Coco C; Cellini N; Picciocchi A; Genovesi D; Mantini G; Barbaro B; Cogliandolo S; Mattana C; Ambesi-Impiombato F; Tedesco M; Cosimelli M
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(5):1067-75. PubMed ID: 9539561
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of preoperative radiation therapy for resectable rectal adenocarcinoma when combined with oral tegafur-uracil modulated with leucovorin: results from a phase II study.
Uzcudun AE; Batlle JF; Velasco JC; Sánchez Santos ME; Carpeño Jde C; Grande AG; Juberías AM; Piñeiro EH; Olivar LM; García AG
Dis Colon Rectum; 2002 Oct; 45(10):1349-58. PubMed ID: 12394434
[TBL] [Abstract][Full Text] [Related]
8. Preoperative radiotherapy in rectal cancer: treatment results of three different dose regimens.
Klenova A; Parvanova V; Georgiev R; Gesheva N
J BUON; 2006; 11(2):161-6. PubMed ID: 17318965
[TBL] [Abstract][Full Text] [Related]
9. Preoperative chemoradiation of locally advanced T3 rectal cancer combined with an endorectal boost.
Jakobsen A; Mortensen JP; Bisgaard C; Lindebjerg J; Hansen JW; Rafaelsen SR
Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):461-5. PubMed ID: 16226396
[TBL] [Abstract][Full Text] [Related]
10. Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results.
Tjandra JJ; Reading DM; McLachlan SA; Gunn IF; Green MD; McLaughlin SJ; Millar JL; Pedersen JS
Dis Colon Rectum; 2001 Aug; 44(8):1113-22. PubMed ID: 11535850
[TBL] [Abstract][Full Text] [Related]
11. A phase I/II trial of three-dimensionally planned concurrent boost radiotherapy and protracted venous infusion of 5-FU chemotherapy for locally advanced rectal carcinoma.
Myerson RJ; Valentini V; Birnbaum EH; Cellini N; Coco C; Fleshman JW; Gambacorta MA; Genovesi D; Kodner IJ; Picus J; Ratkin GA; Read TE
Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1299-308. PubMed ID: 11483342
[TBL] [Abstract][Full Text] [Related]
12. Early toxicity from preoperative radiotherapy with continuous infusion 5-fluorouracil for resectable adenocarcinoma of the rectum: a Phase II trial for the Trans-Tasman Radiation Oncology Group.
Ngan SY; Burmeister BH; Fisher R; Rischin D; Schache DJ; Kneebone A; MacKay JR; Joseph D; Bell A; Goldstein D
Int J Radiat Oncol Biol Phys; 2001 Jul; 50(4):883-7. PubMed ID: 11429215
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate endorectal brachytherapy for locally advanced rectal cancer in previously irradiated patients.
Chuong MD; Fernandez DC; Shridhar R; Hoffe SE; Saini A; Hunt D; Meredith KL; Biagioli MC
Brachytherapy; 2013; 12(5):457-62. PubMed ID: 23707855
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of downstaging following preoperative radiation therapy for operable T3-T4 rectal cancer.
Kaminsky-Forrett MC; Conroy T; Luporsi E; Peiffert D; Lapeyre M; Boissel P; Guillemin F; Bey P
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):935-41. PubMed ID: 9869213
[TBL] [Abstract][Full Text] [Related]
15. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
16. Preoperative radiochemotherapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum.
Rullier E; Goffre B; Bonnel C; Zerbib F; Caudry M; Saric J
Ann Surg; 2001 Nov; 234(5):633-40. PubMed ID: 11685026
[TBL] [Abstract][Full Text] [Related]
17. T-level downstaging and complete pathologic response after preoperative chemoradiation for advanced rectal cancer result in decreased recurrence and improved disease-free survival.
Theodoropoulos G; Wise WE; Padmanabhan A; Kerner BA; Taylor CW; Aguilar PS; Khanduja KS
Dis Colon Rectum; 2002 Jul; 45(7):895-903. PubMed ID: 12130878
[TBL] [Abstract][Full Text] [Related]
18. Preoperative hyperfractionated radiotherapy for locally advanced rectal cancers: a phase I-II trial.
Allal AS; Bieri S; Bründler MA; Soravia C; Gertsch P; Bernier J; Morel P; Roth AD
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(4):1076-81. PubMed ID: 12419434
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
[TBL] [Abstract][Full Text] [Related]
20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
